Chris Smith | Chief Executive Officer |
Bill Bonello | Chief Financial Officer |
Vishal Sikri | President of our Pharma Services Division, Inivata |
Shashi Kulkarni | President of Lab Operations and CSO |
Alex Nowak | Craig-Hallam Capital |
Andrew Brackmann | William Blair |
David Delahunt | Goldman Sachs |
Puneet Souda | SVB Securities |
Andrew Cooper | Raymond James |
Mark Massaro | BTIG |
Mason Carrico | Stephens |
Tejas Savant | Morgan Stanley |
Dan Brennan | Cowen |
Mike Matson | Needham & Company |
Good day, ladies and gentlemen, and welcome to the NeoGenomics Third Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.
It is now my pleasure to turn the floor over to your host, Mr. Chris Smith, CEO of NeoGenomics. Chris, the floor is yours.